INVICTUS MD STRATE COM NPV (OTCMKTS:IVITF) is a penny stock that has started to engage renewed focus among OTC traders and investors as prices get a little traction once again after a lateral, four-month consolidation. Fueling the recent bounce, IVITF just announced that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations, Acreage Pharms Ltd. located near Edson, Alberta, utilizing a multi-room indoor perpetual growing methodology, will begin its first harvest the first week of August, with the second harvest occurring the following week. Management notes that the company anticipates a harvest to take place approximately monthly going forward. Here are the details.
According to the release, Invictus MD is further pleased to announce that Acreage Pharms has received its development permit for Phase 2 and has broken ground initiating construction on its 27,800 square foot purpose built, multiple room production facility. “All contractors and suppliers necessary for the project have been scheduled. Invictus MD has committed to investing $6.0 million, which will be used to fund the costs of constructing the production facility.”
INVICTUS MD STRATE COM NPV (OTCMKTS:IVITF) bills itself ostensibly as a company that targets small and mid-size companies with “proven brands, strong customer focus, and significant growth potential. We direct the strategy towards profitability and growth for each of our portfolio companies.”
Moreover, according to a basic description used by the company on several finance hubs, they assist their portfolio companies with “business process integration and by structuring and deploying proper capital to support sustained growth.”
That said, from what we could find, it appears this is now really a Canadian cannabis producer.
According to company materials tagged to recent press releases, “Invictus MD Strategies Corp. is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR including an investment in a fully licensed facility, AB Laboratories Inc. as well as the option to now acquire 100% of Acreage Pharms Ltd.; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd.”
Find out when $IVITF stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, shares of IVITF recently got a jolt of juice on the upside when the company announced that its licensed ACMPR production facility will begin its first harvest the first week of August.
“Following our successful harvest at the AB Laboratories production facility as announced earlier, and by securing the development permit for our Alberta production facility, with $30 million cash available and the majority earmarked for building production capacity, Invictus MD is prepared for an exciting year of growth,” said Dan Kriznic, Executive Chairman and CEO, Invictus MD. “Led by one of the industry’s most experienced teams, we are strongly focused on building our shareholder value. With 250 acres of cultivation space that stretches from Alberta to Ontario, allowing for purpose built production facilities rather than retrofitting existing buildings, our large land package allows for building cultivation facilities as demand increases and we will continue the disciplined but agile execution of our business strategy, and further establishing our leadership position as Canada’s cannabis company” added Kriznic.
Recent action has seen 33% tacked on to share pricing for the stock in the past week, a bounce that has taken root amid largely bearish action over the larger time frame. The situation may be worth watching. IVITF has a history of dramatic rallies. Moreover, the name has benefitted from a jump in recent trading volume to the tune of 96% beyond what we have been seeing over the larger time frame.
Currently trading at a market capitalization of $57.3M, IVITF has a significant war chest ($3.2M) of cash on the books, which compares with virtually no total current liabilities. IVITF is pulling in trailing 12-month revenues of $1.7M. However, the company is seeing declines on the top line on a quarterly y/y basis, with revenues falling at -40.9%. We will update the story again soon as further details emerge. For continuing coverage on shares of $IVITF stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!
Disclosure: we hold no position in $IVITF, either long or short, and we have not been compensated for this article.